<!-- template for the static html pages not generated by build e.g., index, guidance , toc -->

<!DOCTYPE HTML>

<html xml:lang="en" xmlns="http://www.w3.org/1999/xhtml" lang="en">
<head>
  <meta charset="UTF-8"/>
  <title></title>

  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <meta name="description" content=" Implemenation Guide" />
  <meta name="author" content="Health Level 7"/>
  <link href="fhir.css" rel="stylesheet"/>


  <!-- Bootstrap core CSS -->

  <!-- Latest compiled and minified CSS -->

  <link href="assets/css/bootstrap.css" rel="stylesheet"/>
  <link href="assets/css/bootstrap-fhir.css" rel="stylesheet"/>
  <link href="assets/css/bootstrap-glyphicons.css" rel="stylesheet">

  <!-- Project extras -->
  <link href="assets/css/project.css" rel="stylesheet"/>
  <link href="assets/css/pygments-manni.css" rel="stylesheet"/>
  <link href="assets/css/jquery-ui.css" rel="stylesheet"/>
  

  <!-- Favicons -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="assets/ico/apple-touch-icon-144-precomposed.png"/>
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="assets/ico/apple-touch-icon-114-precomposed.png"/>
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="assets/ico/apple-touch-icon-72-precomposed.png"/>
  <link rel="apple-touch-icon-precomposed" href="assets/ico/apple-touch-icon-57-precomposed.png"/>
  <link rel="shortcut icon" href="assets/ico/favicon.png"/>


<body markdown="1">
<?xml version="1.0" encoding="UTF-8"?>
<div id="segment-header" class="segment">
  <!-- segment-header -->
  <div class="container"><!-- container -->

    <!-- hl7 logo -->
    <a no-external="true" href="http://hl7.org/fhir">
      <img alt="FHIR Homepage" class="img-responsive logo" src="assets/images/fhir-logo-www.png"/>
    </a>
    <!-- end hl7 logo -->


    <!-- org logo -->
    <!--
<a id="your-logo" no-external="true" href="http://www.hl7.org">
<img height="50" alt="visit the hl7 website" width="42" src="assets/images/hl7-logo.png"/>
</a>

your logo here

[![visit our website](assets/images/org_logo.png)](your web site.html)
{: .img-responsive #org_logo}

can only resize using html  or css ;-(

-->


<a no-external="true" href="http://www.hl7.org">
<img alt="visit our website" class="img-responsive project-logo" src="assets/images/hl7-logo.png"/>
</a>

    <!-- end org logo -->


    <div id="project-status" class="project-status"> <!-- ig title text -->

      
      <strong> Implementation Guide Release 0.0.1</strong>
      

    </div><!-- end ig title text -->

  </div><!-- end container -->
  <div class="container">
    <!-- container -->
  </div>
</div>
<!-- /segment-header -->


<div id="segment-navbar" class="segment">
  <!-- segment-navbar -->
  <div id="stripe">
  </div>
  <div class="container">
    <!-- container -->
    <!-- HEADER CONTENT -->
    <nav class="navbar navbar-inverse">
      <div class="container">
        <button data-target=".navbar-inverse-collapse" class="navbar-toggle" data-toggle="collapse" type="button">
          <span class="icon-bar">
          </span>
          <span class="icon-bar">
          </span>
          <span class="icon-bar">
          </span>
        </button>
        <a class="navbar-brand hidden" href="http://build.fhir.org/index.html">FHIR</a>
        <div class="nav-collapse collapse navbar-inverse-collapse">

       <!-- don't remove the line above - choose what you want  
- [Home](index.html)
- [General Guidance](guidance.html)
- [Profiles and Logical Models](profiles.html)
- [Notice to Balloters](balloters.html)
- [Extensions](extensions.html)
- [Terminology](terminology.html)
- [Search Parameters](searchparams.html)
- [Capability Statements](capstatements.html)
- [Security](security.html)
- [Examples](examples.html)
- [Downloads](downloads.html)

- [General Guidance and Questions <span class="caret"></span>](#){: .dropdown-toggle data-toggle="dropdown"}
    - [eCR Exchange Transactions](ecr-exchange.html)
    - [Triggering / Decision Support](triggering.html)
    - [FHIR Timing and Roll-Out](fhir-timing.html)
    {: .dropdown-menu}
*****no empty lines****

-->
<ul class="nav navbar-nav">
  <li><a href="index.html" class="active">Home</a></li>
  <li><a href="toc.html">Table of Contents</a></li>
  <li><a href="profiles.html">Profiles, Extensions &amp; Transactions</a></li>
  <li><a href="terminology.html">Terminology</a></li>
  <li><a href="capstatements.html">Capability Statements</a></li>
  <li><a href="other.html">Other</a></li>
  <li><a href="downloads.html">Downloads</a></li>
</ul>

<!-- ******* how to create a dropdown menu in md ********
- [Capability Statements <span class="caret"></span>](#){: .dropdown-toggle data-toggle="dropdown"}
    - [Conformance requirements for Server](CapabilityStatement-server.html)
    - [Conformance requirements for Client](CapabilityStatement-client.html)
    {: .dropdown-menu}
-->


             <!--        <ul class="nav navbar-nav">
          <li>
            <a href="index.html">Home</a>
          </li>
          <li>
            <a href="guidance.html">General Guidance</a>
          </li>
          <li>
            <a href="profiles.html">Profiles and Logical Models</a>
          </li>
          <li>
            <a href="structuremaps.html">Mappings</a>
          </li>
          <li>
            <a href="extensions.html">Extensions</a>
          </li>
          <li>
            <a href="terminology.html">Terminology</a>
          </li>
          <li>
            <a href="searchparams.html">Search Parameters</a>
          </li>
          <li>
            <a href="capstatements.html">Capability Statements</a>
          </li>
          <li>
            <a href="security.html">Security</a>
          </li>
          <li>
            <a href="examples.html">Examples</a>
          </li>
          <li>
            <a href="downloads.html">Downloads</a>
          </li>
        </ul> -->
      </div>
      <!-- /.nav-collapse -->
    </div>
    <!-- /.container -->
  </nav>
  <!-- /.navbar -->
  <!-- /HEADER CONTENT -->
</div>
<!-- /container -->
</div>
<!-- /segment-navbar -->


</div>  <!-- /container -->
</div>  <!-- /segment-breadcrumb -->


<div id="page-content-wrapper">  <!-- page content wrapper -->
  <div class="page-content">  <!--page content -->
    <div class="container">  <!-- container -->
      <div class="row">  <!-- row -->
       <div class="inner-wrapper"> <!-- inner-wrapper -->
         <div class="col-12">  <!--col -->
            <!-- content of page -->


<!-- ============BreadCrumb=============== -->

<nav class="breadcrumb">
  
    
    
      
      
      
        <a class="breadcrumb-item btn btn-link btn-sm" href="toc.html">TOC</a><a class="breadcrumb-item" href="index.html">Home</a>
        /
        <a class="breadcrumb-item" href="terminology.html">Terminology</a>
        /
        <span class="breadcrumb-item active">ValueSet-2.16.840.1.113762.1.4.1010.8.ttl</span>
      
      
      
      
    


</nav>



<!-- ============nav-tabs=============== -->


  
    <!--  choose what you want  comment out or Change what you don't note that markdown is not working here -->

<ul class="nav nav-tabs">
  <!-- Content -->
  
  	<li><a
      href="ValueSet-2.16.840.1.113762.1.4.1010.8.html">Content</a></li>
  
    




 
  <!-- XML -->
  
    <li><a
      href="ValueSet-2.16.840.1.113762.1.4.1010.8.xml.html">XML</a></li>
  
    
    <!-- JSON -->
  
    <li><a href="ValueSet-2.16.840.1.113762.1.4.1010.8.json.html">JSON</a></li>
  
 
 
</ul>

    <h2>Turtle Format: ValueSet-2.16.840.1.113762.1.4.1010.8</h2>
  
  


  <!-- ============CONTENT CONTENT=============== -->


<!-- ============ CONTENT CONTENT=============== -->

  <!-- ============ default xml or json content for structuredefinition CONTENT CONTENT=============== -->
  <p>
  Raw <a href="ValueSet-2.16.840.1.113762.1.4.1010.8.ttl" download>ttl</a>
  </p>

<pre class="rdf">
@prefix fhir: &lt;http://hl7.org/fhir/&gt; .
@prefix owl: &lt;http://www.w3.org/2002/07/owl#&gt; .
@prefix rdfs: &lt;http://www.w3.org/2000/01/rdf-schema#&gt; .
@prefix xsd: &lt;http://www.w3.org/2001/XMLSchema#&gt; .

# - resource -------------------------------------------------------------------

 a fhir:ValueSet;
  <a href="http://build.fhir.org/rdf.html#tree-root">fhir:nodeRole</a> fhir:treeRoot;
  <a href="http://build.fhir.org/valueset.html#ValueSet.id">fhir:Resource.id</a> [ <a href="http://build.fhir.org/datatypes.html#id">fhir:value</a> &quot;2.16.840.1.113762.1.4.1010.8&quot;];
  <a href="http://build.fhir.org/valueset.html#ValueSet.meta">fhir:Resource.meta</a> [
     <a href="http://build.fhir.org/datatypes.html#Meta#Meta.versionId">fhir:Meta.versionId</a> [ <a href="http://build.fhir.org/datatypes.html#id">fhir:value</a> &quot;19&quot; ];
     <a href="http://build.fhir.org/datatypes.html#Meta#Meta.lastUpdated">fhir:Meta.lastUpdated</a> [ <a href="http://build.fhir.org/datatypes.html#instant">fhir:value</a> &quot;2018-05-19T01:08:36.000-04:00&quot;^^xsd:dateTime ]
  ];
  <a href="http://build.fhir.org/valueset.html#ValueSet.text">fhir:DomainResource.text</a> [
     <a href="http://build.fhir.org/datatypes.html#Narrative#Narrative.status">fhir:Narrative.status</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;generated&quot; ];
     fhir:Narrative.div &quot;&lt;div xmlns=\&quot;http://www.w3.org/1999/xhtml\&quot;&gt;\n            &lt;h2&gt;Vaccine Clinical Drug&lt;/h2&gt;\n            &lt;p&gt;This value set includes codes from the following code systems:&lt;/p&gt;\n            &lt;ul&gt;\n                &lt;li&gt;Include these codes as defined in \n                    &lt;a href=\&quot;http://www.nlm.nih.gov/research/umls/rxnorm\&quot;&gt;\n                        &lt;code&gt;http://www.nlm.nih.gov/research/umls/rxnorm&lt;/code&gt;\n                    &lt;/a&gt;\n                    &lt;table class=\&quot;none\&quot;&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;\n                                &lt;b&gt;Code&lt;/b&gt;\n                            &lt;/td&gt;\n                            &lt;td&gt;\n                                &lt;b&gt;Display&lt;/b&gt;\n                            &lt;/td&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1005934&lt;/td&gt;\n                            &lt;td&gt;Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain 0.03 MG/ML / Influenza Virus Vaccine, Inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain 0.03 MG/ML Injectable Suspension&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1099936&lt;/td&gt;\n                            &lt;td&gt;Adenovirus Type 4 Vaccine Live 32000 UNT Delayed Release Oral Tablet&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1099940&lt;/td&gt;\n                            &lt;td&gt;Adenovirus Type 7 Vaccine Live 32000 UNT Delayed Release Oral Tablet&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1111370&lt;/td&gt;\n                            &lt;td&gt;0.1 ML Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain 0.09 MG/ML / Influenza Virus Vaccine, Inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.09 MG/ML / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain 0.09 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1190916&lt;/td&gt;\n                            &lt;td&gt;0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Tenivac]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1190919&lt;/td&gt;\n                            &lt;td&gt;0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Tenivac]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1244205&lt;/td&gt;\n                            &lt;td&gt;0.5 ML diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1292432&lt;/td&gt;\n                            &lt;td&gt;0.65 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 UNT/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1292435&lt;/td&gt;\n                            &lt;td&gt;0.65 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 UNT/ML Injection [Zostavax]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1292440&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 40000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 20000 UNT/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1292443&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 40000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 20000 UNT/ML Injection [ProQuad]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1292457&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2700 UNT/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1292459&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2700 UNT/ML Injection [Varivax]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1292826&lt;/td&gt;\n                            &lt;td&gt;Yellow-Fever Virus Vaccine, 17D-204 strain 4000 UNT/ML Injectable Suspension&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1292828&lt;/td&gt;\n                            &lt;td&gt;Yellow-Fever Virus Vaccine, 17D-204 strain 4000 UNT/ML Injectable Suspension [YF-Vax]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1298819&lt;/td&gt;\n                            &lt;td&gt;influenza A-California-7-2009-(H1N1)v-like virus vaccine 158000000 UNT/ML Nasal Spray&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1300189&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.005 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1300191&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.005 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Adacel]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1300205&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.005 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1300206&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.005 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Adacel]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1300308&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.02 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1300310&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.02 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Daptacel]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1300368&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 5 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1300370&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 5 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Boostrix]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1300377&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 5 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1300378&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 5 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Boostrix]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1300382&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1300384&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe [Infanrix]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1300385&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1300386&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Infanrix]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1300466&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1300468&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML Injection [ActHIB]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1300781&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1300783&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 MG/ML Prefilled Syringe [Ixiaro]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1300808&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.07 MG/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1300810&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.07 MG/ML Injection [Hiberix]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1301889&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / Human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1301891&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / Human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML Prefilled Syringe [Cervarix]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1361668&lt;/td&gt;\n                            &lt;td&gt;1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1367005&lt;/td&gt;\n                            &lt;td&gt;Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.09 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / Influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.09 MG/ML Injectable Solution [Flublok 2012-2013 Formula]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1427052&lt;/td&gt;\n                            &lt;td&gt;0.25 ML Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Brisbane-60-2008-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2013-2014 Formula]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1437911&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.005 MG/ML / meningococcal group C polysaccharide 0.01 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.01 MG/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1437916&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.005 MG/ML / meningococcal group C polysaccharide 0.01 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.01 MG/ML Injection [MenHibrix]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1442210&lt;/td&gt;\n                            &lt;td&gt;Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.09 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Injectable Solution [Flublok 2013-2014 Formula]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1486496&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe [Typhim VI]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1537485&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Afluria 2014-2015 Formula]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1537494&lt;/td&gt;\n                            &lt;td&gt;Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Afluria 2014-2015 Formula]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1537521&lt;/td&gt;\n                            &lt;td&gt;Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.09 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Injectable Solution [Flublok 2014-2015 Formula]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1537526&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Flucelvax 2014-2015 Formula]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1537532&lt;/td&gt;\n                            &lt;td&gt;Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Fluvirin 2014-2015 Formula]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1537534&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluvirin 2014-2015 Formula]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1537540&lt;/td&gt;\n                            &lt;td&gt;Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Fluzone 2014-2015 Formula]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1537545&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.12 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.12 MG/ML Prefilled Syringe [Fluzone High-Dose 2014-2015 Formula]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1537551&lt;/td&gt;\n                            &lt;td&gt;0.1 ML Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.09 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Prefilled Syringe [Fluzone Intradermal 2014-2015 Formula]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1537554&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluzone 2014-2015 Formula]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1537556&lt;/td&gt;\n                            &lt;td&gt;0.25 ML Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluzone 2014-2015 Formula]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1537561&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Brisbane-60-2008-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2014-2015 Formula]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1537564&lt;/td&gt;\n                            &lt;td&gt;Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Brisbane-60-2008-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2014-2015 Formula]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1541627&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Brisbane-60-2008-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluarix Quad 2014-2015 Formula]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1543407&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluarix 2014-2015 Formula]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1543772&lt;/td&gt;\n                            &lt;td&gt;Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 50000000 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 50000000 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 50000000 MG/ML / Influenza Virus Vaccine, Live Attenuated, B-Brisbane-60-2008 strain 50000000 MG/ML Nasal Spray [Flumist 2014-2015 Formula]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1544625&lt;/td&gt;\n                            &lt;td&gt;Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), Inactivated 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Flulaval 2014-2015 Formula]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1544633&lt;/td&gt;\n                            &lt;td&gt;Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), Inactivated 0.03 MG/ML / Influenza B virus vaccine, B-Brisbane-60-2008-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Flulaval Quad 2014-2015 Formula]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1546095&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), Inactivated 0.03 MG/ML / Influenza B virus vaccine, B-Brisbane-60-2008-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Flulaval Quad 2014-2015 Formula]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1547580&lt;/td&gt;\n                            &lt;td&gt;0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 10A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 11A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 12F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 14 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 15B vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 17F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 18C vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 19A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 19F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 2 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 20 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 22F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 23F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 3 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 33F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 4 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 5 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 6B vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 7F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 8 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 9N vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 9V vaccine 0.05 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1547582&lt;/td&gt;\n                            &lt;td&gt;0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 10A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 11A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 12F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 14 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 15B vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 17F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 18C vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 19A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 19F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 2 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 20 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 22F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 23F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 3 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 33F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 4 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 5 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 6B vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 7F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 8 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 9N vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 9V vaccine 0.05 MG/ML Prefilled Syringe [Pneumovax 23]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1593135&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen 0.12 MG/ML / Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen 0.12 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1593140&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen 0.12 MG/ML / Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen 0.12 MG/ML Prefilled Syringe [Trumenba]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1597094&lt;/td&gt;\n                            &lt;td&gt;0.5 ML L1 protein, Human papillomavirus type 11 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 16 Vaccine 0.12 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 31 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 33 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 45 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 52 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 58 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 6 Vaccine 0.06 MG/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1597099&lt;/td&gt;\n                            &lt;td&gt;0.5 ML L1 protein, Human papillomavirus type 11 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 16 Vaccine 0.12 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 31 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 33 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 45 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 52 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 58 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 6 Vaccine 0.06 MG/ML Injection [Gardasil 9]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1597101&lt;/td&gt;\n                            &lt;td&gt;0.5 ML L1 protein, Human papillomavirus type 11 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 16 Vaccine 0.12 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 31 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 33 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 45 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 52 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 58 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 6 Vaccine 0.06 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1597103&lt;/td&gt;\n                            &lt;td&gt;0.5 ML L1 protein, Human papillomavirus type 11 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 16 Vaccine 0.12 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 31 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 33 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 45 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 52 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 58 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 6 Vaccine 0.06 MG/ML Prefilled Syringe [Gardasil 9]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1601402&lt;/td&gt;\n                            &lt;td&gt;0.5 ML meningococcal group B vaccine 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 0.05 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1601407&lt;/td&gt;\n                            &lt;td&gt;0.5 ML meningococcal group B vaccine 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 0.05 MG/ML Prefilled Syringe [Bexsero]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1607803&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1607808&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Quadracel]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1653484&lt;/td&gt;\n                            &lt;td&gt;BCG, Live, Tice Strain 50 MG/ML Topical Suspension&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1653579&lt;/td&gt;\n                            &lt;td&gt;BCG, Live, Tice Strain 50 MG Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1657139&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/Brisbane/10/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1657144&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/Brisbane/10/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax 2015-2016]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1657231&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1657236&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2015-2016]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1657325&lt;/td&gt;\n                            &lt;td&gt;influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1657330&lt;/td&gt;\n                            &lt;td&gt;influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluvirin 2015-2016]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1657334&lt;/td&gt;\n                            &lt;td&gt;influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1657339&lt;/td&gt;\n                            &lt;td&gt;influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [FluLaval Quadrivalent 2015-2016]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1657844&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1658058&lt;/td&gt;\n                            &lt;td&gt;1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1658060&lt;/td&gt;\n                            &lt;td&gt;1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injection [Havrix]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1658065&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1658066&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injection [Havrix]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1658100&lt;/td&gt;\n                            &lt;td&gt;1 ML Hepatitis A Vaccine, Inactivated 50 UNT/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1658102&lt;/td&gt;\n                            &lt;td&gt;1 ML Hepatitis A Vaccine, Inactivated 50 UNT/ML Injection [Vaqta]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1658105&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Hepatitis A Vaccine, Inactivated 50 UNT/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1658106&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Hepatitis A Vaccine, Inactivated 50 UNT/ML Injection [Vaqta]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1658142&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1658144&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1658149&lt;/td&gt;\n                            &lt;td&gt;1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1658150&lt;/td&gt;\n                            &lt;td&gt;1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection [Recombivax]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1658154&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1658155&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection [Recombivax]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1658156&lt;/td&gt;\n                            &lt;td&gt;1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1658157&lt;/td&gt;\n                            &lt;td&gt;1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1658226&lt;/td&gt;\n                            &lt;td&gt;0.5 ML meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 0.1 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.1 MG/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1658228&lt;/td&gt;\n                            &lt;td&gt;0.5 ML meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 0.1 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.1 MG/ML Injection [Menomune A/C/Y/W-135]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1658239&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Yellow-Fever Virus Vaccine, 17D-204 strain 4000 UNT/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1658241&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Yellow-Fever Virus Vaccine, 17D-204 strain 4000 UNT/ML Injection [YF-Vax]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1658470&lt;/td&gt;\n                            &lt;td&gt;0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 10A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 11A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 12F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 14 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 15B vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 17F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 18C vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 19A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 19F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 2 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 20 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 22F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 23F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 3 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 33F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 4 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 5 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 6B vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 7F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 8 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 9N vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 9V vaccine 0.05 MG/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1658472&lt;/td&gt;\n                            &lt;td&gt;0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 10A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 11A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 12F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 14 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 15B vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 17F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 18C vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 19A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 19F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 2 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 20 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 22F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 23F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 3 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 33F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 4 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 5 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 6B vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 7F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 8 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 9N vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 9V vaccine 0.05 MG/ML Injection [Pneumovax 23]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1658701&lt;/td&gt;\n                            &lt;td&gt;influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1658706&lt;/td&gt;\n                            &lt;td&gt;influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone 2015-2016]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1658711&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.12 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1658714&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.12 MG/ML Prefilled Syringe [Fluzone 2015-2016]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1659729&lt;/td&gt;\n                            &lt;td&gt;influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2015-2016]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1659737&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2015-2016]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1659746&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1659748&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2015-2016]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1659754&lt;/td&gt;\n                            &lt;td&gt;0.25 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1659755&lt;/td&gt;\n                            &lt;td&gt;0.25 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2015-2016]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1659981&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1659983&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluvirin 2015-2016]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1660924&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1660929&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Injection [Flublok 2015-2016]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1661111&lt;/td&gt;\n                            &lt;td&gt;0.1 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1661113&lt;/td&gt;\n                            &lt;td&gt;0.1 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2015-2016]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1661802&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1661807&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria 2015-2016]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1661810&lt;/td&gt;\n                            &lt;td&gt;influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1661812&lt;/td&gt;\n                            &lt;td&gt;influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Afluria 2015-2016]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1664475&lt;/td&gt;\n                            &lt;td&gt;influenza A virus A/Bolivia/559/2013 (H1N1) antigen 50000000 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 50000000 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 50000000 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 50000000 MG/ML Nasal Spray&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1664644&lt;/td&gt;\n                            &lt;td&gt;influenza A virus A/Bolivia/559/2013 (H1N1) antigen 50000000 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 50000000 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 50000000 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 50000000 MG/ML Nasal Spray [Flumist 2015-2016]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1724010&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.015 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.015 MG/ML / influenza B virus B/Brisbane/9/2014 antigen 0.015 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1724012&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.015 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.015 MG/ML / influenza B virus B/Brisbane/9/2014 antigen 0.015 MG/ML Prefilled Syringe [FLUAD 2015-2016]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1794440&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1794448&lt;/td&gt;\n                            &lt;td&gt;influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1794451&lt;/td&gt;\n                            &lt;td&gt;0.25 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1799106&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2016-2017]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1799109&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1799123&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2016-2017]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1799205&lt;/td&gt;\n                            &lt;td&gt;influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Flulaval Quadrivalent 2016-2017]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1799398&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1799403&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe [Afluria 2016-2017]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1799411&lt;/td&gt;\n                            &lt;td&gt;influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Injectable Suspension&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1799413&lt;/td&gt;\n                            &lt;td&gt;influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Injectable Suspension [Afluria 2016-2017]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1801070&lt;/td&gt;\n                            &lt;td&gt;0.1 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1801075&lt;/td&gt;\n                            &lt;td&gt;0.1 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2016-2017]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1801082&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe [Fluad 2016-2017]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1801152&lt;/td&gt;\n                            &lt;td&gt;influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Injectable Suspension&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1801157&lt;/td&gt;\n                            &lt;td&gt;influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Injectable Suspension [Fluvirin 2016-2017]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1801161&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1801163&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe [Fluvirin 2016-2017]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1801174&lt;/td&gt;\n                            &lt;td&gt;0.25 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2016-2017]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1801178&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.12 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1801183&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.12 MG/ML Prefilled Syringe [Fluzone 2016-2017]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1801186&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2016-2017]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1801187&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1801189&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2016-2017]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1801193&lt;/td&gt;\n                            &lt;td&gt;influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2016-2017]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1801606&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/Brisbane/10/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Hong Kong/259/2010 antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1801611&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/Brisbane/10/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Hong Kong/259/2010 antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2016-2017]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1801824&lt;/td&gt;\n                            &lt;td&gt;influenza A virus A/Bolivia/559/2013 (H1N1) antigen 50000000 MG/ML / influenza A virus A/New Caledonia/71/2014 (H3N2) antigen 50000000 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 50000000 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 50000000 MG/ML Nasal Spray&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1801830&lt;/td&gt;\n                            &lt;td&gt;influenza A virus A/Bolivia/559/2013 (H1N1) antigen 50000000 MG/ML / influenza A virus A/New Caledonia/71/2014 (H3N2) antigen 50000000 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 50000000 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 50000000 MG/ML Nasal Spray [Flumist Quadrivalent 2016-2017]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1803019&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1803024&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML Injection [Flublok 2016-2017]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1858963&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2016-2017 Formula]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1858966&lt;/td&gt;\n                            &lt;td&gt;influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Afluria Quadrivalent 2016-2017 Formula]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1876705&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1876710&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injection [Stamaril]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1928302&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1928307&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2017-2018]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1928312&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1928317&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2017-2018]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1928324&lt;/td&gt;\n                            &lt;td&gt;influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1928329&lt;/td&gt;\n                            &lt;td&gt;influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Flulaval Quadrivalent 2017-2018]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1928330&lt;/td&gt;\n                            &lt;td&gt;0.25 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1928332&lt;/td&gt;\n                            &lt;td&gt;0.25 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2017-2018]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1928336&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2017-2018]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1928339&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.12 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.12 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1928344&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.12 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.12 MG/ML Prefilled Syringe [Fluzone 2017-2018]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1928354&lt;/td&gt;\n                            &lt;td&gt;influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1928356&lt;/td&gt;\n                            &lt;td&gt;influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2017-2018]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1928358&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1928359&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2017-2018]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1928360&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1928362&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Flublok Quadrivalent 2017-2018]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1928468&lt;/td&gt;\n                            &lt;td&gt;0.1 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1928470&lt;/td&gt;\n                            &lt;td&gt;0.1 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2017-2018]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1928472&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1928880&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML Injection [Flublok 2017-2018]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1928960&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1928965&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe [Fluad 2017-2018]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1928969&lt;/td&gt;\n                            &lt;td&gt;influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Injectable Suspension&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1928974&lt;/td&gt;\n                            &lt;td&gt;influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Injectable Suspension [Fluvirin 2017-2018]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1928982&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe [Fluvirin 2017-2018]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1946984&lt;/td&gt;\n                            &lt;td&gt;influenza A virus A/New Caledonia/71/2014 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Slovenia/2903/2015 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Brisbane/60/2008 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML Nasal Spray&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1946986&lt;/td&gt;\n                            &lt;td&gt;influenza A virus A/New Caledonia/71/2014 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Slovenia/2903/2015 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Brisbane/60/2008 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML Nasal Spray [Flumist Quadrivalent 2017-2018]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1994347&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;1994352&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injection [Heplisav-B]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;204527&lt;/td&gt;\n                            &lt;td&gt;tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;205255&lt;/td&gt;\n                            &lt;td&gt;diphtheria toxoid vaccine, inactivated 25 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;205259&lt;/td&gt;\n                            &lt;td&gt;0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 4 UNT/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;205262&lt;/td&gt;\n                            &lt;td&gt;tetanus toxoid vaccine, inactivated 20 UNT/ML Injectable Suspension&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;207269&lt;/td&gt;\n                            &lt;td&gt;meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 0.1 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.1 MG/ML Injectable Solution [Menomune A/C/Y/W-135]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;213744&lt;/td&gt;\n                            &lt;td&gt;BCG, Live, Tice Strain 50 MG/ML Topical Suspension [Tice BCG]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;251817&lt;/td&gt;\n                            &lt;td&gt;meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML Injectable Solution&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;318242&lt;/td&gt;\n                            &lt;td&gt;tetanus toxoid vaccine, inactivated 8 UNT/ML Injectable Solution&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;347699&lt;/td&gt;\n                            &lt;td&gt;meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 0.1 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.1 MG/ML Injectable Solution&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;389159&lt;/td&gt;\n                            &lt;td&gt;BCG, Live, Tice Strain 12.5 MG/ML Irrigation Solution&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;606375&lt;/td&gt;\n                            &lt;td&gt;Hepatitis A Vaccine, Inactivated 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;727782&lt;/td&gt;\n                            &lt;td&gt;1 ML Hepatitis A Vaccine, Inactivated 50 UNT/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;762598&lt;/td&gt;\n                            &lt;td&gt;Typhoid Vaccine Live Ty21a 2000000000 UNT Delayed Release Oral Capsule&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;762602&lt;/td&gt;\n                            &lt;td&gt;Typhoid Vaccine Live Ty21a 2000000000 UNT Delayed Release Oral Capsule [Vivotif]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;763103&lt;/td&gt;\n                            &lt;td&gt;poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Injectable Solution&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;763106&lt;/td&gt;\n                            &lt;td&gt;poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Injectable Solution [Ipol]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;792156&lt;/td&gt;\n                            &lt;td&gt;0.5 ML tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;797638&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;797641&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML Injection [Menactra]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;797643&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;797645&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML Prefilled Syringe [Menactra]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;798271&lt;/td&gt;\n                            &lt;td&gt;0.5 ML L1 protein, Human papillomavirus type 11 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 16 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 6 Vaccine 0.04 MG/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;798274&lt;/td&gt;\n                            &lt;td&gt;0.5 ML L1 protein, Human papillomavirus type 11 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 16 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 6 Vaccine 0.04 MG/ML Injection [Gardasil]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;798276&lt;/td&gt;\n                            &lt;td&gt;0.5 ML L1 protein, Human papillomavirus type 11 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 16 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 6 Vaccine 0.04 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;798278&lt;/td&gt;\n                            &lt;td&gt;0.5 ML L1 protein, Human papillomavirus type 11 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 16 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 6 Vaccine 0.04 MG/ML Prefilled Syringe [Gardasil]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;798297&lt;/td&gt;\n                            &lt;td&gt;Human-Bovine Reassortant Rotavirus Strain G1 Vaccine 1100000 UNT/ML / Human-Bovine Reassortant Rotavirus Strain G2 Vaccine 1400000 UNT/ML / Human-Bovine Reassortant Rotavirus Strain G3 Vaccine 1100000 UNT/ML / Human-Bovine Reassortant Rotavirus Strain G4 Vaccine 1000000 UNT/ML / Human-Bovine Reassortant Rotavirus Strain P1A[8] Vaccine 1150000 UNT/ML Oral Suspension&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;798300&lt;/td&gt;\n                            &lt;td&gt;Human-Bovine Reassortant Rotavirus Strain G1 Vaccine 1100000 UNT/ML / Human-Bovine Reassortant Rotavirus Strain G2 Vaccine 1400000 UNT/ML / Human-Bovine Reassortant Rotavirus Strain G3 Vaccine 1100000 UNT/ML / Human-Bovine Reassortant Rotavirus Strain G4 Vaccine 1000000 UNT/ML / Human-Bovine Reassortant Rotavirus Strain P1A[8] Vaccine 1150000 UNT/ML Oral Suspension [RotaTeq]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;798375&lt;/td&gt;\n                            &lt;td&gt;Mumps Virus Vaccine Live, Jeryl Lynn Strain 40000 UNT/ML Injectable Solution&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;798378&lt;/td&gt;\n                            &lt;td&gt;Mumps Virus Vaccine Live, Jeryl Lynn Strain 40000 UNT/ML Injectable Solution [Mumpsvax]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;798426&lt;/td&gt;\n                            &lt;td&gt;1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;798428&lt;/td&gt;\n                            &lt;td&gt;1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;798429&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;798430&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;798440&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.265 MG/ML / Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;798443&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.265 MG/ML / Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection [COMVAX]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;798447&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.265 MG/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;798451&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.265 MG/ML Injection [PedvaxHIB]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;798477&lt;/td&gt;\n                            &lt;td&gt;1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;798479&lt;/td&gt;\n                            &lt;td&gt;1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;798481&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;798482&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;803364&lt;/td&gt;\n                            &lt;td&gt;1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;803367&lt;/td&gt;\n                            &lt;td&gt;1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Twinrix]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;803369&lt;/td&gt;\n                            &lt;td&gt;1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;803371&lt;/td&gt;\n                            &lt;td&gt;1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;804183&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 25000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;804186&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 25000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML Injection [M-M-R II]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;805375&lt;/td&gt;\n                            &lt;td&gt;0.5 ML acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;805378&lt;/td&gt;\n                            &lt;td&gt;0.5 ML acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Pentacel]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;805379&lt;/td&gt;\n                            &lt;td&gt;diphtheria toxoid vaccine, inactivated 13.4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;805576&lt;/td&gt;\n                            &lt;td&gt;Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 1000000 UNT/ML Oral Suspension&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;805579&lt;/td&gt;\n                            &lt;td&gt;Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 1000000 UNT/ML Oral Suspension [Rotarix]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;807222&lt;/td&gt;\n                            &lt;td&gt;Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;807225&lt;/td&gt;\n                            &lt;td&gt;Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;807239&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;807273&lt;/td&gt;\n                            &lt;td&gt;0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;807277&lt;/td&gt;\n                            &lt;td&gt;0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;829987&lt;/td&gt;\n                            &lt;td&gt;0.5 ML acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;829989&lt;/td&gt;\n                            &lt;td&gt;0.5 ML acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe [PEDIARIX]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;830237&lt;/td&gt;\n                            &lt;td&gt;Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Suspension&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;830243&lt;/td&gt;\n                            &lt;td&gt;1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;830245&lt;/td&gt;\n                            &lt;td&gt;1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Recombivax]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;830252&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;830253&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Recombivax]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;830261&lt;/td&gt;\n                            &lt;td&gt;1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;830263&lt;/td&gt;\n                            &lt;td&gt;1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injection [Recombivax]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;830460&lt;/td&gt;\n                            &lt;td&gt;1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;830463&lt;/td&gt;\n                            &lt;td&gt;1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injection [RabAvert]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;830467&lt;/td&gt;\n                            &lt;td&gt;1 ML rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;830470&lt;/td&gt;\n                            &lt;td&gt;1 ML rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML Injection [Imovax]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;830549&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;830552&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Kinrix]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;830555&lt;/td&gt;\n                            &lt;td&gt;0.5 ML acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;830557&lt;/td&gt;\n                            &lt;td&gt;0.5 ML acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe [Kinrix]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;832679&lt;/td&gt;\n                            &lt;td&gt;BACILLUS ANTHRACIS STRAIN V770-NP1-R ANTIGENS 0.1 MG/ML Injectable Suspension&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;832682&lt;/td&gt;\n                            &lt;td&gt;BACILLUS ANTHRACIS STRAIN V770-NP1-R ANTIGENS 0.1 MG/ML Injectable Suspension [Biothrax]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;836634&lt;/td&gt;\n                            &lt;td&gt;1 ML Hepatitis A Vaccine, Inactivated 50 UNT/ML Prefilled Syringe [Vaqta]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;836635&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Hepatitis A Vaccine, Inactivated 50 UNT/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;836636&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Hepatitis A Vaccine, Inactivated 50 UNT/ML Prefilled Syringe [Vaqta]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;854977&lt;/td&gt;\n                            &lt;td&gt;pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 10A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 11A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 12F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 14 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 15B vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 17F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 18C vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 19A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 19F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 2 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 20 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 22F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 23F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 3 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 33F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 4 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 5 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 6B vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 7F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 8 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 9N vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 9V vaccine 0.05 MG/ML Injectable Solution&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;854981&lt;/td&gt;\n                            &lt;td&gt;pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 10A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 11A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 12F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 14 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 15B vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 17F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 18C vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 19A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 19F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 2 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 20 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 22F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 23F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 3 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 33F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 4 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 5 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 6B vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 7F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 8 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 9N vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 9V vaccine 0.05 MG/ML Injectable Solution [Pneumovax 23]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;857965&lt;/td&gt;\n                            &lt;td&gt;0.25 ML Influenza Virus Vaccine, Inactivated A-Brisbane-59-2007, IVR-148 (H1N1) strain 0.03 MG/ML / Influenza Virus Vaccine, Inactivated A-Uruguay-716-2007, NYMC X-175C (H3N2) strain 0.03 MG/ML / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain 0.03 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;864704&lt;/td&gt;\n                            &lt;td&gt;influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML Injectable Suspension&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;864781&lt;/td&gt;\n                            &lt;td&gt;0.25 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;864797&lt;/td&gt;\n                            &lt;td&gt;0.5 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;901514&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML Injection&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;901518&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML Injection [Menveo]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;901640&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0088 MG/ML / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML Prefilled Syringe&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                        &lt;tr&gt;\n                            &lt;td&gt;901644&lt;/td&gt;\n                            &lt;td&gt;0.5 ML Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0088 MG/ML / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML Prefilled Syringe [Prevnar 13]&lt;/td&gt;\n                            &lt;td/&gt;\n                        &lt;/tr&gt;\n                    &lt;/table&gt;\n                &lt;/li&gt;\n            &lt;/ul&gt;\n        &lt;/div&gt;&quot;
  ];
  <a href="http://build.fhir.org/valueset.html#ValueSet.url">fhir:ValueSet.url</a> [ <a href="http://build.fhir.org/datatypes.html#uri">fhir:value</a> &quot;http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.8&quot;];
  <a href="http://build.fhir.org/valueset.html#ValueSet.version">fhir:ValueSet.version</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;20180519&quot;];
  <a href="http://build.fhir.org/valueset.html#ValueSet.name">fhir:ValueSet.name</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;Vaccine Clinical Drug&quot;];
  <a href="http://build.fhir.org/valueset.html#ValueSet.status">fhir:ValueSet.status</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;active&quot;];
  <a href="http://build.fhir.org/valueset.html#ValueSet.date">fhir:ValueSet.date</a> [ <a href="http://build.fhir.org/datatypes.html#dateTime">fhir:value</a> &quot;2018-05-19T01:00:03-04:00&quot;^^xsd:dateTime];
  <a href="http://build.fhir.org/valueset.html#ValueSet.publisher">fhir:ValueSet.publisher</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;HL7 Terminology&quot;];
  <a href="http://build.fhir.org/valueset.html#ValueSet.compose">fhir:ValueSet.compose</a> [
     <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include">fhir:ValueSet.compose.include</a> [
       <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
       <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.system">fhir:ValueSet.compose.include.system</a> [ <a href="http://build.fhir.org/datatypes.html#uri">fhir:value</a> &quot;http://www.nlm.nih.gov/research/umls/rxnorm&quot; ];
       <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept">fhir:ValueSet.compose.include.concept</a> [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 0;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1005934&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain 0.03 MG/ML / Influenza Virus Vaccine, Inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain 0.03 MG/ML Injectable Suspension&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 1;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1099936&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;Adenovirus Type 4 Vaccine Live 32000 UNT Delayed Release Oral Tablet&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 2;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1099940&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;Adenovirus Type 7 Vaccine Live 32000 UNT Delayed Release Oral Tablet&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 3;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1111370&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.1 ML Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain 0.09 MG/ML / Influenza Virus Vaccine, Inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.09 MG/ML / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain 0.09 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 4;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1190916&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Tenivac]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 5;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1190919&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Tenivac]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 6;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1244205&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 7;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1292432&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.65 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 UNT/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 8;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1292435&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.65 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 UNT/ML Injection [Zostavax]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 9;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1292440&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 40000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 20000 UNT/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 10;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1292443&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 40000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 20000 UNT/ML Injection [ProQuad]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 11;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1292457&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2700 UNT/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 12;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1292459&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2700 UNT/ML Injection [Varivax]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 13;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1292826&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;Yellow-Fever Virus Vaccine, 17D-204 strain 4000 UNT/ML Injectable Suspension&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 14;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1292828&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;Yellow-Fever Virus Vaccine, 17D-204 strain 4000 UNT/ML Injectable Suspension [YF-Vax]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 15;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1298819&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A-California-7-2009-(H1N1)v-like virus vaccine 158000000 UNT/ML Nasal Spray&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 16;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1300189&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.005 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 17;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1300191&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.005 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Adacel]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 18;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1300205&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.005 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 19;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1300206&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.005 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Adacel]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 20;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1300308&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.02 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 21;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1300310&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.02 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Daptacel]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 22;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1300368&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 5 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 23;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1300370&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 5 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Boostrix]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 24;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1300377&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 5 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 25;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1300378&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 5 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Boostrix]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 26;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1300382&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 27;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1300384&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe [Infanrix]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 28;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1300385&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 29;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1300386&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Infanrix]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 30;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1300466&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 31;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1300468&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML Injection [ActHIB]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 32;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1300781&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 33;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1300783&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 MG/ML Prefilled Syringe [Ixiaro]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 34;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1300808&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.07 MG/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 35;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1300810&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.07 MG/ML Injection [Hiberix]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 36;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1301889&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / Human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 37;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1301891&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / Human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML Prefilled Syringe [Cervarix]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 38;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1361668&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 39;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1367005&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.09 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / Influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.09 MG/ML Injectable Solution [Flublok 2012-2013 Formula]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 40;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1427052&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.25 ML Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Brisbane-60-2008-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2013-2014 Formula]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 41;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1437911&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.005 MG/ML / meningococcal group C polysaccharide 0.01 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.01 MG/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 42;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1437916&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.005 MG/ML / meningococcal group C polysaccharide 0.01 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.01 MG/ML Injection [MenHibrix]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 43;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1442210&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.09 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Injectable Solution [Flublok 2013-2014 Formula]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 44;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1486496&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe [Typhim VI]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 45;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1537485&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Afluria 2014-2015 Formula]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 46;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1537494&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Afluria 2014-2015 Formula]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 47;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1537521&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.09 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Injectable Solution [Flublok 2014-2015 Formula]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 48;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1537526&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Flucelvax 2014-2015 Formula]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 49;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1537532&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Fluvirin 2014-2015 Formula]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 50;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1537534&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluvirin 2014-2015 Formula]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 51;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1537540&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Fluzone 2014-2015 Formula]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 52;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1537545&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.12 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.12 MG/ML Prefilled Syringe [Fluzone High-Dose 2014-2015 Formula]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 53;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1537551&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.1 ML Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.09 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Prefilled Syringe [Fluzone Intradermal 2014-2015 Formula]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 54;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1537554&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluzone 2014-2015 Formula]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 55;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1537556&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.25 ML Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluzone 2014-2015 Formula]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 56;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1537561&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Brisbane-60-2008-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2014-2015 Formula]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 57;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1537564&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Brisbane-60-2008-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2014-2015 Formula]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 58;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1541627&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Brisbane-60-2008-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluarix Quad 2014-2015 Formula]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 59;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1543407&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluarix 2014-2015 Formula]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 60;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1543772&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 50000000 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 50000000 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 50000000 MG/ML / Influenza Virus Vaccine, Live Attenuated, B-Brisbane-60-2008 strain 50000000 MG/ML Nasal Spray [Flumist 2014-2015 Formula]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 61;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1544625&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), Inactivated 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Flulaval 2014-2015 Formula]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 62;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1544633&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), Inactivated 0.03 MG/ML / Influenza B virus vaccine, B-Brisbane-60-2008-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Flulaval Quad 2014-2015 Formula]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 63;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1546095&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), Inactivated 0.03 MG/ML / Influenza B virus vaccine, B-Brisbane-60-2008-like virus 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Flulaval Quad 2014-2015 Formula]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 64;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1547580&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 10A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 11A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 12F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 14 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 15B vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 17F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 18C vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 19A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 19F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 2 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 20 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 22F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 23F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 3 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 33F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 4 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 5 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 6B vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 7F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 8 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 9N vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 9V vaccine 0.05 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 65;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1547582&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 10A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 11A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 12F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 14 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 15B vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 17F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 18C vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 19A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 19F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 2 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 20 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 22F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 23F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 3 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 33F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 4 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 5 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 6B vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 7F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 8 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 9N vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 9V vaccine 0.05 MG/ML Prefilled Syringe [Pneumovax 23]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 66;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1593135&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen 0.12 MG/ML / Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen 0.12 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 67;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1593140&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen 0.12 MG/ML / Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen 0.12 MG/ML Prefilled Syringe [Trumenba]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 68;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1597094&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML L1 protein, Human papillomavirus type 11 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 16 Vaccine 0.12 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 31 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 33 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 45 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 52 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 58 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 6 Vaccine 0.06 MG/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 69;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1597099&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML L1 protein, Human papillomavirus type 11 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 16 Vaccine 0.12 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 31 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 33 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 45 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 52 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 58 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 6 Vaccine 0.06 MG/ML Injection [Gardasil 9]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 70;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1597101&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML L1 protein, Human papillomavirus type 11 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 16 Vaccine 0.12 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 31 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 33 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 45 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 52 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 58 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 6 Vaccine 0.06 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 71;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1597103&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML L1 protein, Human papillomavirus type 11 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 16 Vaccine 0.12 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 31 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 33 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 45 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 52 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 58 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 6 Vaccine 0.06 MG/ML Prefilled Syringe [Gardasil 9]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 72;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1601402&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML meningococcal group B vaccine 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 0.05 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 73;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1601407&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML meningococcal group B vaccine 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 0.05 MG/ML Prefilled Syringe [Bexsero]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 74;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1607803&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 75;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1607808&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Quadracel]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 76;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1653484&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;BCG, Live, Tice Strain 50 MG/ML Topical Suspension&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 77;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1653579&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;BCG, Live, Tice Strain 50 MG Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 78;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1657139&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/Brisbane/10/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 79;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1657144&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/Brisbane/10/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax 2015-2016]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 80;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1657231&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 81;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1657236&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2015-2016]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 82;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1657325&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 83;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1657330&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluvirin 2015-2016]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 84;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1657334&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 85;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1657339&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [FluLaval Quadrivalent 2015-2016]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 86;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1657844&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 87;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1658058&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 88;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1658060&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injection [Havrix]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 89;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1658065&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 90;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1658066&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injection [Havrix]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 91;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1658100&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;1 ML Hepatitis A Vaccine, Inactivated 50 UNT/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 92;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1658102&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;1 ML Hepatitis A Vaccine, Inactivated 50 UNT/ML Injection [Vaqta]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 93;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1658105&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Hepatitis A Vaccine, Inactivated 50 UNT/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 94;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1658106&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Hepatitis A Vaccine, Inactivated 50 UNT/ML Injection [Vaqta]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 95;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1658142&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 96;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1658144&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 97;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1658149&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 98;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1658150&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection [Recombivax]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 99;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1658154&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 100;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1658155&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection [Recombivax]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 101;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1658156&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 102;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1658157&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 103;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1658226&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 0.1 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.1 MG/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 104;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1658228&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 0.1 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.1 MG/ML Injection [Menomune A/C/Y/W-135]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 105;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1658239&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Yellow-Fever Virus Vaccine, 17D-204 strain 4000 UNT/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 106;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1658241&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Yellow-Fever Virus Vaccine, 17D-204 strain 4000 UNT/ML Injection [YF-Vax]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 107;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1658470&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 10A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 11A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 12F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 14 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 15B vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 17F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 18C vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 19A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 19F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 2 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 20 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 22F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 23F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 3 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 33F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 4 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 5 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 6B vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 7F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 8 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 9N vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 9V vaccine 0.05 MG/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 108;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1658472&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 10A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 11A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 12F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 14 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 15B vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 17F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 18C vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 19A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 19F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 2 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 20 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 22F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 23F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 3 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 33F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 4 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 5 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 6B vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 7F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 8 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 9N vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 9V vaccine 0.05 MG/ML Injection [Pneumovax 23]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 109;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1658701&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 110;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1658706&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone 2015-2016]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 111;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1658711&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.12 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 112;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1658714&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.12 MG/ML Prefilled Syringe [Fluzone 2015-2016]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 113;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1659729&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2015-2016]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 114;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1659737&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2015-2016]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 115;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1659746&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 116;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1659748&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2015-2016]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 117;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1659754&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.25 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 118;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1659755&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.25 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2015-2016]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 119;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1659981&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 120;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1659983&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluvirin 2015-2016]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 121;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1660924&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 122;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1660929&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Injection [Flublok 2015-2016]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 123;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1661111&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.1 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 124;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1661113&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.1 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2015-2016]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 125;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1661802&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 126;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1661807&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria 2015-2016]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 127;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1661810&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 128;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1661812&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Afluria 2015-2016]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 129;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1664475&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A virus A/Bolivia/559/2013 (H1N1) antigen 50000000 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 50000000 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 50000000 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 50000000 MG/ML Nasal Spray&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 130;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1664644&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A virus A/Bolivia/559/2013 (H1N1) antigen 50000000 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 50000000 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 50000000 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 50000000 MG/ML Nasal Spray [Flumist 2015-2016]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 131;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1724010&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.015 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.015 MG/ML / influenza B virus B/Brisbane/9/2014 antigen 0.015 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 132;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1724012&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.015 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.015 MG/ML / influenza B virus B/Brisbane/9/2014 antigen 0.015 MG/ML Prefilled Syringe [FLUAD 2015-2016]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 133;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1794440&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 134;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1794448&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 135;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1794451&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.25 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 136;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1799106&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2016-2017]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 137;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1799109&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 138;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1799123&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2016-2017]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 139;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1799205&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Flulaval Quadrivalent 2016-2017]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 140;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1799398&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 141;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1799403&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe [Afluria 2016-2017]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 142;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1799411&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Injectable Suspension&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 143;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1799413&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Injectable Suspension [Afluria 2016-2017]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 144;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1801070&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.1 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 145;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1801075&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.1 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2016-2017]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 146;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1801082&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe [Fluad 2016-2017]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 147;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1801152&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Injectable Suspension&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 148;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1801157&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Injectable Suspension [Fluvirin 2016-2017]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 149;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1801161&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 150;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1801163&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe [Fluvirin 2016-2017]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 151;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1801174&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.25 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2016-2017]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 152;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1801178&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.12 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 153;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1801183&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.12 MG/ML Prefilled Syringe [Fluzone 2016-2017]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 154;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1801186&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2016-2017]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 155;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1801187&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 156;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1801189&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2016-2017]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 157;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1801193&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2016-2017]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 158;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1801606&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/Brisbane/10/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Hong Kong/259/2010 antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 159;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1801611&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/Brisbane/10/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Hong Kong/259/2010 antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2016-2017]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 160;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1801824&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A virus A/Bolivia/559/2013 (H1N1) antigen 50000000 MG/ML / influenza A virus A/New Caledonia/71/2014 (H3N2) antigen 50000000 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 50000000 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 50000000 MG/ML Nasal Spray&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 161;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1801830&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A virus A/Bolivia/559/2013 (H1N1) antigen 50000000 MG/ML / influenza A virus A/New Caledonia/71/2014 (H3N2) antigen 50000000 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 50000000 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 50000000 MG/ML Nasal Spray [Flumist Quadrivalent 2016-2017]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 162;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1803019&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 163;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1803024&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML Injection [Flublok 2016-2017]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 164;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1858963&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2016-2017 Formula]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 165;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1858966&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Afluria Quadrivalent 2016-2017 Formula]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 166;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1876705&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 167;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1876710&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injection [Stamaril]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 168;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1928302&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 169;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1928307&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2017-2018]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 170;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1928312&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 171;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1928317&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2017-2018]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 172;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1928324&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 173;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1928329&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Flulaval Quadrivalent 2017-2018]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 174;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1928330&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.25 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 175;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1928332&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.25 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2017-2018]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 176;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1928336&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2017-2018]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 177;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1928339&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.12 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.12 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 178;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1928344&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.12 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.12 MG/ML Prefilled Syringe [Fluzone 2017-2018]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 179;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1928354&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 180;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1928356&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2017-2018]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 181;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1928358&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 182;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1928359&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2017-2018]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 183;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1928360&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 184;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1928362&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Flublok Quadrivalent 2017-2018]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 185;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1928468&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.1 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 186;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1928470&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.1 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2017-2018]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 187;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1928472&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 188;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1928880&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML Injection [Flublok 2017-2018]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 189;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1928960&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 190;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1928965&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe [Fluad 2017-2018]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 191;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1928969&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Injectable Suspension&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 192;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1928974&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Injectable Suspension [Fluvirin 2017-2018]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 193;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1928982&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe [Fluvirin 2017-2018]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 194;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1946984&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A virus A/New Caledonia/71/2014 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Slovenia/2903/2015 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Brisbane/60/2008 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML Nasal Spray&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 195;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1946986&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A virus A/New Caledonia/71/2014 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Slovenia/2903/2015 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Brisbane/60/2008 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML Nasal Spray [Flumist Quadrivalent 2017-2018]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 196;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1994347&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 197;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;1994352&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injection [Heplisav-B]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 198;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;204527&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 199;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;205255&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;diphtheria toxoid vaccine, inactivated 25 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 200;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;205259&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 4 UNT/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 201;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;205262&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;tetanus toxoid vaccine, inactivated 20 UNT/ML Injectable Suspension&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 202;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;207269&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 0.1 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.1 MG/ML Injectable Solution [Menomune A/C/Y/W-135]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 203;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;213744&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;BCG, Live, Tice Strain 50 MG/ML Topical Suspension [Tice BCG]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 204;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;251817&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML Injectable Solution&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 205;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;318242&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;tetanus toxoid vaccine, inactivated 8 UNT/ML Injectable Solution&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 206;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;347699&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 0.1 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.1 MG/ML Injectable Solution&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 207;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;389159&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;BCG, Live, Tice Strain 12.5 MG/ML Irrigation Solution&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 208;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;606375&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;Hepatitis A Vaccine, Inactivated 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 209;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;727782&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;1 ML Hepatitis A Vaccine, Inactivated 50 UNT/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 210;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;762598&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;Typhoid Vaccine Live Ty21a 2000000000 UNT Delayed Release Oral Capsule&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 211;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;762602&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;Typhoid Vaccine Live Ty21a 2000000000 UNT Delayed Release Oral Capsule [Vivotif]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 212;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;763103&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Injectable Solution&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 213;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;763106&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Injectable Solution [Ipol]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 214;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;792156&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 215;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;797638&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 216;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;797641&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML Injection [Menactra]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 217;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;797643&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 218;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;797645&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML Prefilled Syringe [Menactra]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 219;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;798271&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML L1 protein, Human papillomavirus type 11 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 16 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 6 Vaccine 0.04 MG/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 220;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;798274&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML L1 protein, Human papillomavirus type 11 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 16 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 6 Vaccine 0.04 MG/ML Injection [Gardasil]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 221;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;798276&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML L1 protein, Human papillomavirus type 11 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 16 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 6 Vaccine 0.04 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 222;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;798278&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML L1 protein, Human papillomavirus type 11 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 16 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 6 Vaccine 0.04 MG/ML Prefilled Syringe [Gardasil]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 223;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;798297&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;Human-Bovine Reassortant Rotavirus Strain G1 Vaccine 1100000 UNT/ML / Human-Bovine Reassortant Rotavirus Strain G2 Vaccine 1400000 UNT/ML / Human-Bovine Reassortant Rotavirus Strain G3 Vaccine 1100000 UNT/ML / Human-Bovine Reassortant Rotavirus Strain G4 Vaccine 1000000 UNT/ML / Human-Bovine Reassortant Rotavirus Strain P1A[8] Vaccine 1150000 UNT/ML Oral Suspension&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 224;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;798300&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;Human-Bovine Reassortant Rotavirus Strain G1 Vaccine 1100000 UNT/ML / Human-Bovine Reassortant Rotavirus Strain G2 Vaccine 1400000 UNT/ML / Human-Bovine Reassortant Rotavirus Strain G3 Vaccine 1100000 UNT/ML / Human-Bovine Reassortant Rotavirus Strain G4 Vaccine 1000000 UNT/ML / Human-Bovine Reassortant Rotavirus Strain P1A[8] Vaccine 1150000 UNT/ML Oral Suspension [RotaTeq]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 225;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;798375&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;Mumps Virus Vaccine Live, Jeryl Lynn Strain 40000 UNT/ML Injectable Solution&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 226;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;798378&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;Mumps Virus Vaccine Live, Jeryl Lynn Strain 40000 UNT/ML Injectable Solution [Mumpsvax]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 227;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;798426&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 228;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;798428&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 229;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;798429&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 230;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;798430&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 231;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;798440&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.265 MG/ML / Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 232;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;798443&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.265 MG/ML / Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection [COMVAX]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 233;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;798447&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.265 MG/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 234;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;798451&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.265 MG/ML Injection [PedvaxHIB]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 235;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;798477&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 236;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;798479&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 237;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;798481&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 238;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;798482&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 239;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;803364&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 240;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;803367&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Twinrix]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 241;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;803369&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 242;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;803371&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 243;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;804183&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 25000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 244;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;804186&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 25000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML Injection [M-M-R II]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 245;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;805375&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 246;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;805378&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Pentacel]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 247;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;805379&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;diphtheria toxoid vaccine, inactivated 13.4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 248;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;805576&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 1000000 UNT/ML Oral Suspension&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 249;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;805579&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 1000000 UNT/ML Oral Suspension [Rotarix]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 250;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;807222&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 251;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;807225&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 252;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;807239&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 253;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;807273&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 254;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;807277&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 255;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;829987&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 256;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;829989&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe [PEDIARIX]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 257;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;830237&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Suspension&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 258;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;830243&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 259;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;830245&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Recombivax]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 260;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;830252&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 261;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;830253&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Recombivax]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 262;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;830261&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 263;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;830263&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injection [Recombivax]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 264;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;830460&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 265;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;830463&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injection [RabAvert]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 266;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;830467&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;1 ML rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 267;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;830470&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;1 ML rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML Injection [Imovax]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 268;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;830549&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 269;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;830552&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Kinrix]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 270;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;830555&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 271;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;830557&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe [Kinrix]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 272;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;832679&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;BACILLUS ANTHRACIS STRAIN V770-NP1-R ANTIGENS 0.1 MG/ML Injectable Suspension&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 273;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;832682&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;BACILLUS ANTHRACIS STRAIN V770-NP1-R ANTIGENS 0.1 MG/ML Injectable Suspension [Biothrax]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 274;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;836634&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;1 ML Hepatitis A Vaccine, Inactivated 50 UNT/ML Prefilled Syringe [Vaqta]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 275;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;836635&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Hepatitis A Vaccine, Inactivated 50 UNT/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 276;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;836636&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Hepatitis A Vaccine, Inactivated 50 UNT/ML Prefilled Syringe [Vaqta]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 277;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;854977&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 10A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 11A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 12F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 14 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 15B vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 17F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 18C vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 19A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 19F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 2 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 20 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 22F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 23F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 3 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 33F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 4 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 5 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 6B vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 7F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 8 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 9N vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 9V vaccine 0.05 MG/ML Injectable Solution&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 278;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;854981&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 10A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 11A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 12F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 14 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 15B vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 17F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 18C vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 19A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 19F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 2 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 20 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 22F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 23F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 3 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 33F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 4 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 5 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 6B vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 7F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 8 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 9N vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 9V vaccine 0.05 MG/ML Injectable Solution [Pneumovax 23]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 279;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;857965&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.25 ML Influenza Virus Vaccine, Inactivated A-Brisbane-59-2007, IVR-148 (H1N1) strain 0.03 MG/ML / Influenza Virus Vaccine, Inactivated A-Uruguay-716-2007, NYMC X-175C (H3N2) strain 0.03 MG/ML / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain 0.03 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 280;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;864704&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML Injectable Suspension&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 281;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;864781&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.25 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 282;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;864797&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 283;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;901514&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML Injection&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 284;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;901518&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML Injection [Menveo]&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 285;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;901640&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0088 MG/ML / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML Prefilled Syringe&quot; ]       ], [
         <a href="http://build.fhir.org/rdf.html#index">fhir:index</a> 286;
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.code">fhir:ValueSet.compose.include.concept.code</a> [ <a href="http://build.fhir.org/datatypes.html#code">fhir:value</a> &quot;901644&quot; ];
         <a href="http://build.fhir.org/valueset.html#ValueSet.compose.include.concept.display">fhir:ValueSet.compose.include.concept.display</a> [ <a href="http://build.fhir.org/datatypes.html#string">fhir:value</a> &quot;0.5 ML Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0088 MG/ML / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML Prefilled Syringe [Prevnar 13]&quot; ]       ]     ]
  ].

# - ontology header ------------------------------------------------------------

 a owl:Ontology;
  owl:imports fhir:fhir.ttl.

</pre>



<!-- ============ default xml or json content CONTENT CONTENT=============== -->


<!-- simple format links
<p>
Formats: <a href="ValueSet-2.16.840.1.113762.1.4.1010.8.html">Narrative</a>, <a href="ValueSet-2.16.840.1.113762.1.4.1010.8.xml.html">XML</a>, <a href="ValueSet-2.16.840.1.113762.1.4.1010.8.json.html">JSON</a>, <a href="ValueSet-2.16.840.1.113762.1.4.1010.8.ttl.html">Turtle</a>
</p>
-->


  <!-- ==============END CONTENT END CONTENT=================== -->



  <!-- ==============END CONTENT END CONTENT=================== -->


</div>  <!-- col -->
</div>  <!-- /inner-wrapper -->
</div>  <!-- /row -->
</div>  <!-- /container -->
</div>  <!-- /page content -->
</div>  <!-- /page content wrapper -->





</div>

    </div>  <!-- /inner-wrapper -->
            </div>  <!-- /row -->
        </div>  <!-- /container -->

    </div>  <!-- /segment-content -->

<!--status-bar-->

<div id="segment-footer" class="segment" igtool="footer">  <!-- segment-footer -->
  <div class="container">  <!-- container -->
   <div class="inner-wrapper">
    <p>
      ccda Version: 0.0.1  &reg;&copy; <a style="color: #81BEF7" href="http://build.fhir.org/">FHIR Version: 4.0.0</a> (IG Publisher v4.0.0-a53ec6ee1b) generated on Thu, May 23, 2019 14:53-0700.
      | <a style="color: #81BEF7" href="https://gforge.hl7.org/gf/project/fhir/tracker/?action=TrackerItemAdd&amp;tracker_id=677">Propose a change</a>
        <a style="color: #81BEF7" rel="license" href="http://build.fhir.org/license.html"><img style="border-style: none;" alt="CC0" src="cc0.png"/></a>
        </span>
        </p>
   </div>  <!-- /inner-wrapper -->
  </div>  <!-- /container -->
 </div>  <!-- /segment-footer -->
  <!-- disqus thread -->
  <!-- disqus -->
  <!-- end disqus -->

 <div id="segment-post-footer" class="segment hidden">  <!-- segment-post-footer -->
  <div class="container">  <!-- container -->
  </div>  <!-- /container -->
 </div>  <!-- /segment-post-footer -->

 <!-- JS and analytics only. -->
<!-- Bootstrap core JavaScript
================================================== -->
<!-- Placed at the end of the document so the pages load faster -->
<script src="./assets/js/jquery.js"> </script>     <!-- note keep space here, otherwise it will be transformed to empty tag -> fails -->
<script src="./assets/js/bootstrap.min.js"> </script>
<script src="./assets/js/respond.min.js"> </script>
<script src="./assets/js/anchor.min.js"> </script>
<script src="./assets/js/fhir.js"> </script>

<!-- Analytics Below
================================================== -->

<!-- add acnhors before the closing body tag. -->
<script> anchors.add()</script>
</body>
</html>

